Illumina Inc

Illumina shines a light on the mysteries of the genome with its next-generation DNA sequencing technology. This is one of ARK’s Cathie Woods’ favorite genomic stocks and for good reason. The disruptive company sits at the forefront of DNA technology by enabling researchers to sequence DNA and RNA faster, more effectively, and more affordably.

$102.97
(as of Feb 10, 12:19 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for Illumina Inc

Stock Price
$102.97
Ticker Symbol
ILMN
Exchange
NASDAQ

Industry Information for Illumina Inc

Sector
Healthcare
Industry
Diagnostics & Research

Company Description for Illumina Inc

Country
USA
Full Time Employees
10,590

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.

Fundamentals for Illumina Inc

Market Capitalization
$17,614,114,816
EBITDA
$730,000,000
Dividends per Share
P/E Ratio
Forward P/E Ratio
24.88
Earnings per Share
$-7.69
Earnings per Share Estimate Next Year
$5.19
Profit Margin
-36.11%
Shares Outstanding
158,600,000
Percent Owned by Insiders
0.27%
Percent Owned by Institutions
107.31%
52-Week High
$156.66
52-Week Low
$97.36

Technical Indicators for Illumina Inc

50-Day Moving Average
$137.31
200-Day Moving Average
$127.36
RSI
23.64
6.02

Analyst Ratings for Illumina Inc

Strong Buy
9
Buy
3
Hold
12
Sell
1
Strong Sell
0

News About Illumina Inc

Feb 6, 2025, 4:48 PM EST
Illumina (NASDAQ:ILMN) Beats Q4 Sales Targets See more.
Feb 5, 2025, 10:01 AM EST
Exploring the Latest 13F Filing and Investment Shifts See more.
Feb 5, 2025, 8:13 AM EST
Illumina (ILMN) Reports Earnings Tomorrow: What To Expect See more.
Feb 4, 2025, 6:38 PM EST
Genomic sequencing specialist Illumina(NASDAQ: ILMN) was something of a victim in the U.S.-China trade spat on Tuesday. See more.
Feb 4, 2025, 2:21 PM EST
(Updates with PVH comment starting in the fourth paragraph.) See more.